Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cell Culture
2.2. Immunoprecipitations
2.3. Preparation of Tissue Homogenates
2.4. Western Blotting
2.5. H2S production Assays
2.6. Cysteine Production Assay
2.7. Statistical Analysis
3. Results
3.1. Expression of Cystathionine γ-Lyase and Cystathionine β-Synthase in HD
3.2. Decreased CSE and CBS Activities in Q175 Mice
3.3. Huntingtin Interacts with CSE and Modulates Its Catalytic Activity
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993, 72, 971–983. [Google Scholar] [CrossRef]
- McColgan, P.; Tabrizi, S.J. Huntington’s disease: A clinical review. Eur. J. Neurol. 2018, 25, 24–34. [Google Scholar] [CrossRef] [PubMed]
- Tabrizi, S.J.; Flower, M.D.; Ross, C.A.; Wild, E.J. Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 2020, 16, 529–546. [Google Scholar] [CrossRef]
- Morris, L.A.; O’Callaghan, C.; Le Heron, C. Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington’s Disease. Mov. Disord. 2022, 37, 1149–1163. [Google Scholar] [CrossRef]
- Cha, J.H. Transcriptional signatures in Huntington’s disease. Prog. Neurobiol. 2007, 83, 228–248. [Google Scholar] [CrossRef] [Green Version]
- Ament, S.A.; Pearl, J.R.; Cantle, J.P.; Bragg, R.M.; Skene, P.J.; Coffey, S.R.; Bergey, D.E.; Wheeler, V.C.; MacDonald, M.E.; Baliga, N.S.; et al. Transcriptional regulatory networks underlying gene expression changes in Huntington’s disease. Mol. Syst. Biol. 2018, 14, e7435. [Google Scholar] [CrossRef]
- Malla, B.; Guo, X.; Senger, G.; Chasapopoulou, Z.; Yildirim, F. A Systematic Review of Transcriptional Dysregulation in Huntington’s Disease Studied by RNA Sequencing. Front. Genet. 2021, 12, 751033. [Google Scholar] [CrossRef]
- Grima, J.C.; Daigle, J.G.; Arbez, N.; Cunningham, K.C.; Zhang, K.; Ochaba, J.; Geater, C.; Morozko, E.; Stocksdale, J.; Glatzer, J.C.; et al. Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron 2017, 94, 93–107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sbodio, J.I.; Snyder, S.H.; Paul, B.D. Transcriptional control of amino acid homeostasis is disrupted in Huntington’s disease. Proc. Natl. Acad. Sci. USA 2016, 113, 8843–8848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kumar, A.; Ratan, R.R. Oxidative Stress and Huntington’s Disease: The Good, The Bad, and The Ugly. J. Huntingt. Dis. 2016, 5, 217–237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sbodio, J.I.; Snyder, S.H.; Paul, B.D. Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington’s disease. Proc. Natl. Acad. Sci. USA 2018, 115, 780–785. [Google Scholar] [CrossRef] [Green Version]
- Eshraghi, M.; Karunadharma, P.P.; Blin, J.; Shahani, N.; Ricci, E.P.; Michel, A.; Urban, N.T.; Galli, N.; Sharma, M.; Ramirez-Jarquin, U.N.; et al. Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. Nat. Commun. 2021, 12, 1461. [Google Scholar] [CrossRef]
- Paul, B.D.; Sbodio, J.I.; Xu, R.; Vandiver, M.S.; Cha, J.Y.; Snowman, A.M.; Snyder, S.H. Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington’s disease. Nature 2014, 509, 96–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paul, B.D. Cysteine metabolism and hydrogen sulfide signaling in Huntington’s disease. Free Radic. Biol. Med. 2022, 186, 93–98. [Google Scholar] [CrossRef]
- Frederick, N.M.; Bertho, J.; Patel, K.K.; Petr, G.T.; Bakradze, E.; Smith, S.B.; Rosenberg, P.A. Dysregulation of system xc− expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice. Neurochem. Int. 2014, 76, 59–69. [Google Scholar] [CrossRef] [Green Version]
- Paul, B.D.; Sbodio, J.I.; Snyder, S.H. Cysteine Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol. Sci 2018, 39, 513–524. [Google Scholar] [CrossRef]
- Paul, B.D.; Snyder, S.H. H2S signalling through protein sulfhydration and beyond. Nat. Rev. Mol. Cell Biol. 2012, 13, 499–507. [Google Scholar] [CrossRef]
- Paul, B.D.; Snyder, S.H. H2S: A Novel Gasotransmitter that Signals by Sulfhydration. Trends Biochem. Sci. 2015, 40, 687–700. [Google Scholar] [CrossRef] [Green Version]
- Paul, B.D.; Snyder, S.H. Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem. Pharmacol. 2018, 149, 101–109. [Google Scholar] [CrossRef]
- Ishii, I.; Akahoshi, N.; Yamada, H.; Nakano, S.; Izumi, T.; Suematsu, M. Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. J. Biol. Chem. 2010, 285, 26358–26368. [Google Scholar] [CrossRef] [Green Version]
- Mani, S.; Yang, G.; Wang, R. A critical life-supporting role for cystathionine gamma-lyase in the absence of dietary cysteine supply. Free Radic. Biol. Med. 2011, 50, 1280–1287. [Google Scholar] [CrossRef] [PubMed]
- Vandiver, M.S.; Paul, B.D.; Xu, R.; Karuppagounder, S.; Rao, F.; Snowman, A.M.; Ko, H.S.; Lee, Y.I.; Dawson, V.L.; Dawson, T.M.; et al. Sulfhydration mediates neuroprotective actions of parkin. Nat. Commun. 2013, 4, 1626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Giovinazzo, D.; Bursac, B.; Sbodio, J.I.; Nalluru, S.; Vignane, T.; Snowman, A.M.; Albacarys, L.M.; Sedlak, T.W.; Torregrossa, R.; Whiteman, M.; et al. Hydrogen sulfide is neuroprotective in Alzheimer’s disease by sulfhydrating GSK3beta and inhibiting Tau hyperphosphorylation. Proc. Natl. Acad. Sci. USA 2021, 118, e2017225118. [Google Scholar] [CrossRef]
- Davoli, A.; Greco, V.; Spalloni, A.; Guatteo, E.; Neri, C.; Rizzo, G.R.; Cordella, A.; Romigi, A.; Cortese, C.; Bernardini, S.; et al. Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis. Ann. Neurol. 2015, 77, 697–709. [Google Scholar] [CrossRef] [PubMed]
- Snijder, P.M.; Baratashvili, M.; Grzeschik, N.A.; Leuvenink, H.G.D.; Kuijpers, L.; Huitema, S.; Schaap, O.; Giepmans, B.N.G.; Kuipers, J.; Miljkovic, J.L.; et al. Overexpression of Cystathionine gamma-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3. Mol. Med. 2016, 21, 758–768. [Google Scholar] [CrossRef]
- Panagaki, T.; Lozano-Montes, L.; Janickova, L.; Zuhra, K.; Szabo, M.P.; Majtan, T.; Rainer, G.; Marechal, D.; Herault, Y.; Szabo, C. Overproduction of hydrogen sulfide, generated by cystathionine beta-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome. Redox Biol. 2022, 51, 102233. [Google Scholar] [CrossRef]
- Panagaki, T.; Randi, E.B.; Augsburger, F.; Szabo, C. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome. Proc. Natl. Acad. Sci. USA 2019, 116, 18769–18771. [Google Scholar] [CrossRef] [Green Version]
- Boutell, J.M.; Wood, J.D.; Harper, P.S.; Jones, A.L. Huntingtin interacts with cystathionine beta-synthase. Hum. Mol. Genet. 1998, 7, 371–378. [Google Scholar] [CrossRef] [Green Version]
- Zivanovic, J.; Kouroussis, E.; Kohl, J.B.; Adhikari, B.; Bursac, B.; Schott-Roux, S.; Petrovic, D.; Miljkovic, J.L.; Thomas-Lopez, D.; Jung, Y.; et al. Selective Persulfide Detection Reveals Evolutionarily Conserved Antiaging Effects of S-Sulfhydration. Cell Metab. 2019, 30, 1152–1170.e1113. [Google Scholar] [CrossRef]
- Yang, G.; Wu, L.; Jiang, B.; Yang, W.; Qi, J.; Cao, K.; Meng, Q.; Mustafa, A.K.; Mu, W.; Zhang, S.; et al. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322, 587–590. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morikawa, T.; Kajimura, M.; Nakamura, T.; Hishiki, T.; Nakanishi, T.; Yukutake, Y.; Nagahata, Y.; Ishikawa, M.; Hattori, K.; Takenouchi, T.; et al. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc. Natl. Acad. Sci. USA 2012, 109, 1293–1298. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Enokido, Y.; Suzuki, E.; Iwasawa, K.; Namekata, K.; Okazawa, H.; Kimura, H. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J. 2005, 19, 1854–1856. [Google Scholar] [CrossRef]
- Gaitonde, M.K. A spectrophotometric method for the direct determination of cysteine in the presence of other naturally occurring amino acids. Biochem. J. 1967, 104, 627–633. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, X.; Valencia, A.; Sapp, E.; Masso, N.; Alexander, J.; Reeves, P.; Kegel, K.B.; Aronin, N.; Difiglia, M. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington’s disease. J. Neurosci. 2010, 30, 4552–4561. [Google Scholar] [CrossRef] [PubMed]
- Paul, B.D. Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington’s Disease. Antioxidants 2021, 10, 1468. [Google Scholar] [CrossRef]
- Sen, N.; Paul, B.D.; Gadalla, M.M.; Mustafa, A.K.; Sen, T.; Xu, R.; Kim, S.; Snyder, S.H. Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions. Mol. Cell 2012, 45, 13–24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wright, D.J.; Renoir, T.; Smith, Z.M.; Frazier, A.E.; Francis, P.S.; Thorburn, D.R.; McGee, S.L.; Hannan, A.J.; Gray, L.J. N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington’s disease. Transl. Psychiatry 2015, 5, e492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aoyama, K.; Suh, S.W.; Hamby, A.M.; Liu, J.; Chan, W.Y.; Chen, Y.; Swanson, R.A. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 2006, 9, 119–126. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Paul, B.D.; Sbodio, J.I.; Snyder, S.H. Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels. Antioxidants 2022, 11, 1470. https://doi.org/10.3390/antiox11081470
Paul BD, Sbodio JI, Snyder SH. Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels. Antioxidants. 2022; 11(8):1470. https://doi.org/10.3390/antiox11081470
Chicago/Turabian StylePaul, Bindu D., Juan I. Sbodio, and Solomon H. Snyder. 2022. "Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels" Antioxidants 11, no. 8: 1470. https://doi.org/10.3390/antiox11081470
APA StylePaul, B. D., Sbodio, J. I., & Snyder, S. H. (2022). Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels. Antioxidants, 11(8), 1470. https://doi.org/10.3390/antiox11081470